Source: International Congress 2014 – Airway biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Sankaran, A. Kamath, A. Wilson (Norwich, United Kingdom). Exhaled breath condensate hydrogen peroxide in obstructive airways disease. Eur Respir J 2014; 44: Suppl. 58, 992

Member's Comments

No comment yet.

Related content which might interest you: Monitoring exhaled carbon monoxide in COPD exacerbations Source: International Congress 2014 – Airway biomarkers Year: 2014 Hydrogen sulphide as a biomarker in COPD and asthma Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Hydrogen sulfide (H2S) in sputum and serum as a novel biomarker of COPD Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Exhaled breath condensate pH in exercise-induced bronchoconstriction Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Exhaled particles from small airways in COPD patients – A pilot study Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Assessment of exhaled breath condensate pH in asthma and COPD patients with exacerbation Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Small airways obstruction and exhaled particles in asthma Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008 Exhaled NO but not eosinophilic inflammation is reduced by inhaled corticosteroid treatment in COPD Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Exhaled breath condensate pH in assessment of childhood asthma control Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 Reproducibility of exhaled breath condensate pH in chronic obstructive pulmonary disease Source: Eur Respir J 2005; 25: 269-274 Year: 2005 Double-tracer gas washout in stable asthma and COPD Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Relation of exhaled breath temperature and systemic markers of inflammation and remodelling in stable bronchial asthma Source: International Congress 2016 – Airway biomarkers Year: 2016 Induced sputum and bronchial hyperresponsiveness in COPD patients Source: International Congress 2014 – Airway biomarkers Year: 2014 Decreased levels of bis-S-bimane in exhaled breath condensate of COPD Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Assessment of malondialdehyde in the airways during treatment of COPD exacerbations Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Measuring exhaled hydrogen sulphide (eH2S) levels in asthma Source: International Congress 2016 – Airway biomarkers Year: 2016 Exhaled breath analysis for identifying eosinophilic and neutrophilic inflammation in a mixed population of patients with asthma or COPD Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values Source: International Congress 2014 – The assessment of comorbidities Year: 2014